New Finnish medicines agency combines evaluation and HTA role
This article was originally published in SRA
Executive Summary
Fimea, the new Finnish medicines agency that began its operations on 2 November1,2 will carry out health technology assessments in addition to the evaluation of medicines. According to the Finnish pharma industry association, PIF, the new functions assigned to Fimea make it among the few medicines evaluation agencies to have HTA within its remit.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.
EMA To Get The Ball Rolling On Making CTIS Global
The European Medicines Agency wants to further improve the visibility of data in the Clinical Trials Information System by establishing it as a World Health Organization primary registry.